Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 18/20 | 0.56 |
| ▸ | CA2 | P00918 | 18/20 | 0.56 |
| ▸ | CA9 | Q16790 | 18/20 | 0.56 |
| ▸ | CA12 | O43570 | 13/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 10/20 | 0.56 |
| ▸ | CA4 | P22748 | 5/20 | 0.56 |
| ▸ | CA6 | P23280 | 5/20 | 0.56 |
| ▸ | CA7 | P43166 | 5/20 | 0.56 |
| ▸ | CA13 | Q8N1Q1 | 4/20 | 0.56 |
| ▸ | CA5A | P35218 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 3/20 | 0.48 |
| ▸ | CDK2 | P24941 | 2/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | CDK4 | P11802 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14087150 | 0.92 | CA1 (0.47) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13069903 | 0.85 | CA1 (0.42) | CA1CA2CA9CA12CA14 | |
| SCHEMBL12147044 | 0.84 | CA9 (0.56) | CA1CA2CA9CA12CA14 | |
| SCHEMBL15242220 | 0.83 | CA9 (0.42) | CA1CA2CA9CA12CA14 | |
| SCHEMBL16560578 | 0.82 | CASP6 (0.52) | CA1CA2CA9CA12CA14 | |
| SCHEMBL16560586 | 0.82 | CA1 (0.41) | CA1CA2CA9CA12CA14 | |
| SCHEMBL22375891 | 0.81 | CA9 (0.49) | CA1CA2CA9CA12CA14 | |
| SCHEMBL16557822 | 0.80 | CA1 (0.39) | CA1CA2CA9CA12CA14 | |
| SCHEMBL16348812 | 0.79 | CA9 (0.50) | CA1CA2CA9CA12CA14 | |
| SCHEMBL14079904 | 0.79 | CA9 (0.47) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070113356-A1 | Reactive polysaccharide derivatives, their preparation and their use | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070113356-A1 | Reactive polysaccharide derivatives, their preparation and their use | C1S, H1-0, H1-4 | CA1 1657/4885CA2 3311/4885CA9 2108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.